Sansure Biotech Inc. has established itself as a leading in vitro diagnostics company, offering a comprehensive range of solutions that integrate diagnostic reagents, instruments, and independent clinical laboratory services. By offering customized services and comprehensive solutions, Sansure has made significant strides in various areas, including infectious disease prevention and control, cancer prevention and control, maternal and child health, and blood screening.
Expanding Accessibility and Applications
Sansure’s unwavering dedication to advancing genetic technology has led to the widespread adoption of gene-based diagnostics across various medical institutions. By offering customized services and comprehensive solutions, Sansure has empowered laboratories of all sizes to leverage the benefits of in vitro diagnostics. Sansure’s solutions span a wide range of applications, including infectious disease prevention and control, cancer prevention and control, maternal and child health, and blood screening. The company’s products have obtained certifications in over 65 countries, further cementing its reputation as a trusted global partner in in vitro diagnostics.
Global Reach and Impact
Sansure’s commitment to combating the COVID 19 pandemic extends beyond national borders. Their COVID 19 test kits have been widely adopted in more than 160 countries and regions worldwide. By providing accessible and reliable testing solutions, Sansure has played a significant role in enhancing countries’ testing capabilities and facilitating a better understanding of China’s epidemic prevention strategies. Their contributions have highlighted the strength and expertise of Chinese genetic technology on a global scale.
Sansure Biotech Inc.’s comprehensive solutions in the field of in vitro diagnostics have revolutionized disease detection and diagnosis. The company’s commitment to expanding accessibility and its global impact further solidify its position as a leader in the industry.